About Us

Accelerating the World's Transition to 100+ Living.

We believe the future of healthcare is proactive, personalized, and data-driven. Our mission is to extend the healthy human lifespan through early detection and precision medicine.

10K+ Clients Served·400M+ Genetic Variants Cataloged·$600M Invested in Research·Est. 2013 by Dr. J. Craig Venter·10K+ Clients Served·400M+ Genetic Variants Cataloged·$600M Invested in Research·Est. 2013 by Dr. J. Craig Venter·

We believe the biggest threat to human health is what goes undetected.

Most people only see a doctor when something feels wrong. By then, the window for meaningful intervention has often closed. Human Longevity was built on a different premise: that biology gives us signals long before disease becomes visible — and that catching those signals early is the difference between prevention and treatment.

Our mission is to give every member the most complete picture of their health that science can provide — and the clinical team to act on it.

10,000+

Clients Served

400M+

Genetic Variants Cataloged

$600M

Invested in Research

75,000+

Genomes Sequenced

150GB+

Health Data Per Client

120+

Blood Biomarkers Measured

20+

Peer-Reviewed Publications

Est. 2013

Over a Decade of Science

Since 2013

Founded by Visionaries

In 2000, Dr. J. Craig Venter made history by sequencing the first human genome alongside NIH consortium partners — marking the beginning of the genomic revolution and a new era of precision medicine.

Co-Founder

Dr. J. Craig Venter

Dr. J. Craig Venter

Dr. Venter pioneered the sequencing of the first human genome in 2000 — a scientific landmark that redefined what medicine could know about the human body. He founded Human Longevity in 2013 to translate that science into real clinical care.

His vision: shift medicine from reactive to proactive. Detect disease before it becomes symptomatic. Give every person a complete biological picture of themselves — and the tools to act on it.

Key Milestones

2000

Dr. Venter sequences the first human genome

Dr. J. Craig Venter completed the first sequence of the human genome — a landmark that permanently redefined the future of medicine and what science could know about the human body.

Dr. Venter sequences the first human genome

2013

Human Longevity, Inc founded by Dr. Venter

Dr. Venter founded Human Longevity to apply the power of genomic science to individual health — detecting disease before symptoms ever appear.

Human Longevity, Inc founded by Dr. Venter

2015

San Diego Longevity Care clinic opens

HLI's flagship precision medicine clinic opened in San Diego — the first to offer whole-body MRI, genomic sequencing, and deep biomarker analysis in a single integrated visit.

San Diego Longevity Care clinic opens

2019

Partnership with MGH; launch of Simplify Genomics

Human Longevity partnered with Massachusetts General Hospital and launched Simplify Genomics, expanding access to clinical-grade genomic analysis.

Partnership with MGH; launch of Simplify Genomics

2020

Landmark PNAS publication; 100+ Longevity Programs

HLI published landmark precision medicine research in PNAS and introduced the 100+ Longevity Programs — a new standard in proactive health membership.

Landmark PNAS publication; 100+ Longevity Programs

2022

San Francisco HQ and clinic opens

Human Longevity expanded to San Francisco, opening a new headquarters and clinic to serve the Bay Area and a new generation of health-conscious leaders.

San Francisco HQ and clinic opens

Scientific Advisory Board

Backed by the World's Top Scientific Minds

Aubrey de Grey, PhD

Aubrey de Grey, PhD

Biomedical Gerontologist

Developer of the SENS framework — a roadmap for reversing the cellular damage that drives aging.

Michael Levitt, PhD

Michael Levitt, PhD

Nobel Laureate · Chemistry

2013 Nobel Prize in Chemistry for multiscale computational models of chemical systems.

Geoffrey Hinton, PhD

Geoffrey Hinton, PhD

Nobel Laureate · AI Pioneer

The "Godfather of Deep Learning" — 2024 Nobel Prize in Physics for foundational AI research.

Research

Research Meets Care

Ranked Top 50 Biomedical Companies Globally by Nature Index. Over 20 peer-reviewed publications in Nature Genetics, PNAS, AJHG, and Genome Medicine. Our science isn't theoretical — it directly informs how we care for every client.

Publications20+
Nature Index RankingTop 50
Genomes Sequenced75,000+

PNAS

2020

Deep Phenotyping and Lifetime Trajectories Reveal Singular Aging Phenotypes

Venter JC, et al.

Demonstrating HLI's approach to phenotypic aging analysis — the scientific foundation behind our health intelligence platform.

Read the paper

Click to browse

Partners

Trusted by the world's top institutions

We collaborate with leading research centers, diagnostic innovators, and clinical networks to bring the highest standard of care to every client.

Mass General Brigham
Siemens Healthineers
JCVI
Cleerly
CorTechs.ai
AMRA
Buck Institute
Illumina
Capital Group

And More